Issue

Vol. 30 No. 7 (2018): Vol 30 Issue 7

Copyright (c) 2018 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Isolation and Characterization of Flavonoid from Methanolic Extract of Mirabilis jalapa Linn. Tuber and Evaluation of its Cardioprotective Property

https://doi.org/10.14233/ajchem.2018.21258
D. Shil
Girijananda Chowdhury Institute of Pharmaceutical Science, Azara, Hathkhowapara, Guwahati-781 017, India
S. Dash
Regional Institute of Pharmaceutical Science and Technology, Agartala-799 006, India
D. Laloo
Girijananda Chowdhury Institute of Pharmaceutical Science, Azara, Hathkhowapara, Guwahati-781 017, India
D. Dasgupta
Girijananda Chowdhury Institute of Pharmaceutical Science, Azara, Hathkhowapara, Guwahati-781 017, India

Corresponding Author(s) : D. Shil

dibyendu0684@rediffmail.com

Asian Journal of Chemistry, Vol. 30 No. 7 (2018): Vol 30 Issue 7

Abstract

The aim of the study is to isolate and characterization of bioconstituent present in methanolic extract of Mirabilis jalapa L. tuber and also evaluate the cardioprotective property of the extract as well as isolated compound from the extract. The bioactive constituent flavonoid was isolated from methanolic extract through flash chromatography technique by using solvent system ethyl acetate and methanol. The chemical structure of compound was confirmed on the basis of spectroscopy analysis and identified as 2-(3′, 4′-dihydroxy phenyl)-3,5,7- trihydroxy chromen 4-one. Administration of Mirabilis jalapa extract in higher dose 200 and 400 mg/kg b.w. and isolated compound to doxorubicin-intoxicated rats demonstrated prominent reduction in serum biomarker enzymes, normalization of serum lipid profiles. Also, significant modulation of malondialdehyde (MDA), endogenous non-enzymatic (GSH) and enzymatic (SOD and CAT) antioxidant and detoxification systems compared to doxorubicin control rats. This was achieved due to presence of flavonoid in the methanolic extract of Mirabilis jalapa L. tuber.

Keywords

Mirabilis jalapa L. tuber Flavonoid Doxorubicin Cardioprotective
Shil, D., Dash, S., Laloo, D., & Dasgupta, D. (2018). Isolation and Characterization of Flavonoid from Methanolic Extract of Mirabilis jalapa Linn. Tuber and Evaluation of its Cardioprotective Property. Asian Journal of Chemistry, 30(7), 1579–1584. https://doi.org/10.14233/ajchem.2018.21258
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. V.P. Silja, K.S. Verma and K.V. Mohan, Indian J. Tradit. Knowl., 7, 604 (2008).
  2. J.W. Prakash, Indian J. Tradit. Knowl., 7, 410 (2008).
  3. K.V. Kiran, S.N. Ravi, S. Ramya, R.V. Sahaja, K. Saritha, R.K. Govinda and N.V. Naidu, Int. J. Phytomed., 2, 402 (2010).
  4. N.S. Mahajan, R.L. Jadhav, N.V. Pimpodkar, R.J. Dias and S.B. Garje, J. Pharm. Res., 1, 159 (2008).
  5. D. Shil, S. Dash and D. Laloo, Int. J. Res. Pharm. Sci., 8, 339 (2007).
  6. S. Suroowan and F. Mahomoodally, Clin. Phytosci., 1, 1 (2015); https://doi.org/10.1186/s40816-015-0002-3.
  7. K.R. Khandelwal, Practical Pharmacognosy: Techniques and Experiments, Nirali Prakashan, Pune, India, pp. 25.2-25.9 (2012).
  8. C.K. Kokate, A.P. Purohit and G.B. Gokhale, Pharmacognosy, Nirali Prakashan, Pune, India, pp. 123-124 (2014).
  9. H. Wagner and S. Bladt, Plant Drug Analysis: A Thin Layer Chromatography Atlas, Springer, Thomas Press India Ltd., New Delhi, pp. 1-2 (2004).
  10. E.M. Rani, K. Shilpa and V. Umamaheswara Rao, Int. J. Pharm. Res. Anal., 4, 328 (2014).
  11. Organization for Economic Cooperation and Development (OECD) Guidelines for Acute Toxicity of Chemicals, No. 425 (2008).
  12. A. Kundu, A. Ghosh, N.K. Singh, G.K. Singh, A. Seth, S.K. Maurya, S. Hemalatha and D. Laloo, Pharm. Biol., 54, 2383 (2016); https://doi.org/10.3109/13880209.2016.1157192.
  13. N.R. Barman, P.K. Kar, P.K. Hazam, H.S. Pal, A. Kumar, S. Bhattacharya and P.K. Haldar, Chin. J. Nat. Med., 11, 38 (2013); https://doi.org/10.1016/S1875-5364(13)60005-9.
  14. J. King, ed.: D. Van, The Dehydrogenases or Oxidoreductase-Lactate Dehydrogenase In: Practical Clinical Enzymology, Van Nostrand, London, p. 106 (1965).
  15. S. Okinaka, H. Kumaggai, S. Ebashi, H. Sugita, H. Momoi, Y. Toyokura and Y. Fujie, Arch. Neurol., 4, 520 (1961); https://doi.org/10.1001/archneur.1961.00450110050006.
  16. S. Kaviarasan and C.V. Anuradha, Pharmazie, 62, 299 (2007); https://doi.org/10.1691/ph.2007.4.6648.
  17. W. Richmond, Clin. Chem., 19, 1350 (1973).
  18. G.A. Beaulah, A.M. Sadiq, V. Sivakumar and R.J. Santhi, J. Med. Plants Stud., 2, 1 (2014).
  19. M.K. Singh, M. Faisal, A. Ahmad, A. Sonkar and and J. Yadav, Int. J. Drug Develop. Res., 4, 298 (2012).
  20. H. Ohkawa, N. Ohishi and K. Yagi, Anal. Biochem., 95, 351 (1979); https://doi.org/10.1016/0003-2697(79)90738-3.
  21. S. Marklund, ed.: R.A. Greenwald, Pyrogallol Autoxidation: Handbook of Methods for Oxygen Radical Research,CRC Press, Boca Raton, pp. 243-247 (1985).
  22. H. Aebi, ed.: H.U. Bergmeyer, Catalase: Methods of Enzymatic Analysis, Chemic Academic Press Inc., Verlag, 673-685 (1974).
  23. G.L. Ellman, Arch. Biochem. Biophys., 82, 70 (1959); https://doi.org/10.1016/0003-9861(59)90090-6.
  24. R. Hrdina, V. Gersl, I. Klimtova, T. Simunek, J. Machackova and M. Adamcova, Acta Medica (Cordoba), 43, 75 (2000).
  25. L. Gille and N. Hans, Free Radic. Biol. Med., 23, 775 (1997); https://doi.org/10.1016/S0891-5849(97)00025-7.
  26. I. Taks, B. Matkovics, S. Varga, P. Homolay, G. Feher and T. Seres, Pharmacol. Res., 25, 177 (1992); https://doi.org/10.1016/1043-6618(92)90348-F.
  27. E.Y. Wu, M.T. Smith, G. Bellomo and D. Di Monte, Arch. Biochem. Biophys., 282, 358 (1990); https://doi.org/10.1016/0003-9861(90)90129-M.
  28. X. Liu, Z. Chen, C.C. Chua, Y.S. Ma, G.A. Youngberg, R. Hamdy and B.H.L. Chua, Am. J. Physiol.: Heart Circ. Physiol., 283, H254 (2002); https://doi.org/10.1152/ajpheart.01023.2001.
  29. K.K.M. Ahmed, A.C. Rana and V.K. Dixit, Phytomedicine, 11, 327 (2004); https://doi.org/10.1078/0944711041495146.
  30. Y. Murat, F. Ersin, E. Hasan, U. Muharrem, S. Sadik and M.K. Irmak, Pharmacol. Res., 48, 377 (2003); https://doi.org/10.1016/S1043-6618(03)00185-3.
  31. B.C. Koti, A.H. Vishwanathswamy and W. Jyoti, Indian J. Exp. Biol., 47, 41 (2009).
  32. A.H.M. Thippeswamy, A. Shirodkar, B.C. Koti, A.J. Sadiq, D.M. Praveen, A.V. Swamy and M. Patil, Indian J. Pharmacol., 43, 31 (2011); https://doi.org/10.4103/0253-7613.75663.
  33. S. Bhattacharya, A. Prasanna, P. Majumdar, R.B.S. Kumar and P.K. Haldar, Pharm. Biol., 49, 927 (2011); https://doi.org/10.3109/13880209.2011.557080.
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 2 Download : 1